-
1
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993;72(6):971-83.
-
(1993)
Cell.
, vol.72
, Issue.6
, pp. 971-983
-
-
-
2
-
-
34247120606
-
The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset
-
Andresen JM, Gayan J, Djousse L, Roberts S, Brocklebank D, Cherny SS, et al. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet. 2007;71(Pt 3):295-301.
-
(2007)
Ann Hum Genet.
, vol.71
, pp. 295-301
-
-
Andresen, J.M.1
Gayan, J.2
Djousse, L.3
Roberts, S.4
Brocklebank, D.5
Cherny, S.S.6
-
3
-
-
12144288251
-
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset
-
Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad SciUSA. 2004;101(10):3498-503.
-
(2004)
Proc Natl Acad SciUSA.
, vol.101
, Issue.10
, pp. 3498-3503
-
-
Wexler, N.S.1
Lorimer, J.2
Porter, J.3
Gomez, F.4
Moskowitz, C.5
Shackell, E.6
-
4
-
-
84885404060
-
Correction: Iron accumulates in Huntington's disease neurons: Protection by deferoxamine
-
Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, et al. Correction: Iron accumulates in Huntington's disease neurons: Protection by deferoxamine. PLoS One. 2013;8(11):e77023.
-
(2013)
PLoS One.
, vol.8
, Issue.11
-
-
Chen, J.1
Marks, E.2
Lai, B.3
Zhang, Z.4
Duce, J.A.5
Lam, L.Q.6
-
5
-
-
55349106939
-
Mechanisms of copper ion mediated Huntington's disease progression
-
Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, et al. Mechanisms of copper ion mediated Huntington's disease progression. PLoS One. 2007;2(3):e334.
-
(2007)
PLoS One.
, vol.2
, Issue.3
, pp. e334
-
-
Fox, J.H.1
Kama, J.A.2
Lieberman, G.3
Chopra, R.4
Dorsey, K.5
Chopra, V.6
-
6
-
-
84863806222
-
Alterations in brain transition metals in Huntington disease: An evolving and intricate story
-
Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, Kwong KK, et al. Alterations in brain transition metals in Huntington disease: An evolving and intricate story. Arch Neurol. 2012;69(7):887-93.
-
(2012)
Arch Neurol.
, vol.69
, Issue.7
, pp. 887-893
-
-
Rosas, H.D.1
Chen, Y.I.2
Doros, G.3
Salat, D.H.4
Chen, N.K.5
Kwong, K.K.6
-
7
-
-
84930532225
-
Iron accumulation in the basal ganglia in Huntington's disease: Cross-sectional data from the IMAGE-HD study
-
Dominguez DJ, Ng AC, Poudel G, Stout JC, Churchyard A, Chua P, et al. Iron accumulation in the basal ganglia in Huntington's disease: Cross-sectional data from the IMAGE-HD study. J Neurol Neurosurg Psychiatry. 2015. doi: 10.1136/jnnp-2014-310183
-
(2015)
J Neurol Neurosurg Psychiatry.
-
-
Dominguez, D.J.1
Ng, A.C.2
Poudel, G.3
Stout, J.C.4
Churchyard, A.5
Chua, P.6
-
8
-
-
33751080354
-
Huntingtin inclusion bodies are iron-dependent centers of oxidative events
-
Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP. Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J. 2006;273(23):5428-41.
-
(2006)
FEBS J.
, vol.273
, Issue.23
, pp. 5428-5441
-
-
Firdaus, W.J.1
Wyttenbach, A.2
Giuliano, P.3
Kretz-Remy, C.4
Currie, R.W.5
Arrigo, A.P.6
-
9
-
-
5444229092
-
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
-
Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, et al. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem. 2004;91(2):413-22.
-
(2004)
J Neurochem.
, vol.91
, Issue.2
, pp. 413-422
-
-
Fox, J.H.1
Barber, D.S.2
Singh, B.3
Zucker, B.4
Swindell, M.K.5
Norflus, F.6
-
10
-
-
0030919567
-
Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
-
Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol. 1997;41(5):646-53.
-
(1997)
Ann Neurol.
, vol.41
, Issue.5
, pp. 646-653
-
-
Browne, S.E.1
Bowling, A.C.2
MacGarvey, U.3
Baik, M.J.4
Berger, S.C.5
Muqit, M.M.6
-
11
-
-
84955415198
-
Redoxand non-redox-metal-induced formation of free radicals and their role in human disease
-
ValkoM, Jomova K, Rhodes CJ,Kuca K, Musilek K. Redoxand non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol. 2016;90(1): 1-37.
-
(2016)
Arch Toxicol.
, vol.90
, Issue.1
, pp. 1-37
-
-
Valko, M.1
Jomova, K.2
Rhodes, C.J.3
Kuca, K.4
Musilek, K.5
-
12
-
-
23844482456
-
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
-
NguyenT,HambyA, MassaSM.Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci U S A. 2005;102(33):11840-5.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.33
, pp. 11840-11845
-
-
Nguyen, T.1
Hamby, A.2
Massa, S.M.3
-
13
-
-
34247116462
-
Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age
-
Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA, et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging. 2007;28(6):907-13.
-
(2007)
Neurobiol Aging.
, vol.28
, Issue.6
, pp. 907-913
-
-
Kaur, D.1
Peng, J.2
Chinta, S.J.3
Rajagopalan, S.4
Di Monte, D.A.5
Cherny, R.A.6
-
14
-
-
2542586995
-
Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results
-
Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc. 2004;104(6): 942-50.
-
(2004)
J Am Diet Assoc.
, vol.104
, Issue.6
, pp. 942-950
-
-
Millen, A.E.1
Dodd, K.W.2
Subar, A.F.3
-
15
-
-
0003844789
-
-
National Academy Press, Washington, DC
-
Institute of Medicine (US) Panel on Micronutrients. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. National Academy Press, Washington, DC; 2001.
-
(2001)
Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc
-
-
Institute of Medicine (US) Panel on Micronutrients1
-
16
-
-
84923008546
-
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease
-
Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, et al. Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease. Redox Biol. 2015;4:363-74.
-
(2015)
Redox Biol.
, vol.4
, pp. 363-374
-
-
Berggren, K.L.1
Chen, J.2
Fox, J.3
Miller, J.4
Dodds, L.5
Dugas, B.6
-
17
-
-
16044373842
-
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
-
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493-506.
-
(1996)
Cell.
, vol.87
, Issue.3
, pp. 493-506
-
-
Mangiarini, L.1
Sathasivam, K.2
Seller, M.3
Cozens, B.4
Harper, A.5
Hetherington, C.6
-
18
-
-
0033136692
-
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
-
Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 1999;23(1):181-92.
-
(1999)
Neuron.
, vol.23
, Issue.1
, pp. 181-192
-
-
Hodgson, J.G.1
Agopyan, N.2
Gutekunst, C.A.3
Leavitt, B.R.4
LePiane, F.5
Singaraja, R.6
-
19
-
-
17644368893
-
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
-
Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, Hayden MR. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci. 2005;25(16):4169-80.
-
(2005)
J Neurosci.
, vol.25
, Issue.16
, pp. 4169-4180
-
-
Van Raamsdonk, J.M.1
Pearson, J.2
Slow, E.J.3
Hossain, S.M.4
Leavitt, B.R.5
Hayden, M.R.6
-
20
-
-
67349151319
-
Mouse models of Huntington's disease and methodological considerations for therapeutic trials
-
Ferrante RJ. Mouse models of Huntington's disease and methodological considerations for therapeutic trials. Biochim Biophys Acta. 2009;1792(6):506-20.
-
(2009)
Biochim Biophys Acta.
, vol.1792
, Issue.6
, pp. 506-520
-
-
Ferrante, R.J.1
-
21
-
-
10744227174
-
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
-
Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, DengY, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet. 2003;12(13):1555-67.
-
(2003)
Hum Mol Genet.
, vol.12
, Issue.13
, pp. 1555-1567
-
-
Slow, E.J.1
Van Raamsdonk, J.2
Rogers, D.3
Coleman, S.H.4
Graham, R.K.5
Deng, Y.6
-
22
-
-
84898657803
-
Characterization of striatal neuronal loss and atrophy in the R6/2 mouse model of Huntington's disease
-
Dodds L, Chen J, Berggren K, Fox J. Characterization of striatal neuronal loss and atrophy in the R6/2 mouse model of Huntington's disease. PLoS Curr. 2014;6.
-
(2014)
PLoS Curr.
, vol.6
-
-
Dodds, L.1
Chen, J.2
Berggren, K.3
Fox, J.4
-
23
-
-
33646145729
-
Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer beta-amyloid pathology
-
Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, et al. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer beta-amyloid pathology. J Inorg Biochem. 2006;100(5-6):952-62.
-
(2006)
J Inorg Biochem.
, vol.100
, Issue.5-6
, pp. 952-962
-
-
Maynard, C.J.1
Cappai, R.2
Volitakis, I.3
Cherny, R.A.4
Masters, C.L.5
Li, Q.X.6
-
24
-
-
84906558946
-
Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model
-
Lu Z, Marks E, Chen J, Moline J, Barrows L, Raisbeck M, et al. Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model. Neurobiol Dis. 2014;71:34-42.
-
(2014)
Neurobiol Dis.
, vol.71
, pp. 34-42
-
-
Lu, Z.1
Marks, E.2
Chen, J.3
Moline, J.4
Barrows, L.5
Raisbeck, M.6
-
25
-
-
84885768132
-
Systemic iron homeostasis
-
Ganz T. Systemic iron homeostasis. Physiol Rev. 2013; 93(4):1721-41.
-
(2013)
Physiol Rev.
, vol.93
, Issue.4
, pp. 1721-1741
-
-
Ganz, T.1
-
27
-
-
0041691176
-
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
-
Menalled LB, Sison JD, Dragatsis I, Zeitlin S, ChesseletMF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol. 2003;465(1):11-26.
-
(2003)
J Comp Neurol.
, vol.465
, Issue.1
, pp. 11-26
-
-
Menalled, L.B.1
Sison, J.D.2
Dragatsis, I.3
Zeitlin, S.4
Chesselet, M.F.5
-
28
-
-
84885404060
-
Iron accumulates in Huntington's disease neurons: Protection by deferoxamine
-
Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, et al. Iron accumulates in Huntington's disease neurons: Protection by deferoxamine. PLoS One. 2013;8(10):e77023.
-
(2013)
PLoS One.
, vol.8
, Issue.10
-
-
Chen, J.1
Marks, E.2
Lai, B.3
Zhang, Z.4
Duce, J.A.5
Lam, L.Q.6
-
29
-
-
41849133159
-
Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity
-
Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, et al. Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain. 2008;131(Pt 4):1057-68.
-
(2008)
Brain.
, vol.131
, pp. 1057-1068
-
-
Rosas, H.D.1
Salat, D.H.2
Lee, S.Y.3
Zaleta, A.K.4
Pappu, V.5
Fischl, B.6
-
30
-
-
77956647381
-
Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
-
Duce JA, Tsatsanis A, Cater MA, James SA, Robb E,Wikhe K, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 2010;142(6):857-67.
-
(2010)
Cell.
, vol.142
, Issue.6
, pp. 857-867
-
-
Duce, J.A.1
Tsatsanis, A.2
Cater, M.A.3
James, S.A.4
Robb, E.5
Wikhe, K.6
-
31
-
-
84903720548
-
SAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin
-
McCarthy RC, Park YH, Kosman DJ. sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 2014;15(7):809-15.
-
(2014)
EMBO Rep.
, vol.15
, Issue.7
, pp. 809-815
-
-
McCarthy, R.C.1
Park, Y.H.2
Kosman, D.J.3
-
32
-
-
84883819112
-
Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding
-
Xiao G, Fan Q,Wang X, Zhou B. Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. Proc Natl Acad Sci U S A. 2013;110(37):14995-5000.
-
(2013)
Proc Natl Acad Sci U S A.
, vol.110
, Issue.37
, pp. 14995-15000
-
-
Xiao, G.1
Fan, Q.2
Wang, X.3
Zhou, B.4
-
33
-
-
84915827829
-
BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity
-
Stansfield KH, Bichell TJ, Bowman AB, Guilarte TR. BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J Neurochem. 2014;131(5): 655-66.
-
(2014)
J Neurochem.
, vol.131
, Issue.5
, pp. 655-666
-
-
Stansfield, K.H.1
Bichell, T.J.2
Bowman, A.B.3
Guilarte, T.R.4
-
34
-
-
84923105977
-
Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status
-
Kumar KK, Goodwin CR, Uhouse MA, Bornhorst J, Schwerdtle T, Aschner M, et al. Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status. Metallomics. 2015;7(2): 363-70.
-
(2015)
Metallomics.
, vol.7
, Issue.2
, pp. 363-370
-
-
Kumar, K.K.1
Goodwin, C.R.2
Uhouse, M.A.3
Bornhorst, J.4
Schwerdtle, T.5
Aschner, M.6
-
35
-
-
0030070042
-
Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals
-
Crowe A, Morgan EH. Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals. J Nutr. 1996;126(1):183-94.
-
(1996)
J Nutr.
, vol.126
, Issue.1
, pp. 183-194
-
-
Crowe, A.1
Morgan, E.H.2
-
36
-
-
0030455852
-
Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat
-
Chua AC, Morgan EH. Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res. 1996;55(1-2):39-54.
-
(1996)
Biol Trace Elem Res.
, vol.55
, Issue.1-2
, pp. 39-54
-
-
Chua, A.C.1
Morgan, E.H.2
-
37
-
-
84901060509
-
Role of early life exposure and environment on neurodegeneration: Implications on brain disorders
-
Modgil S, Lahiri DK, Sharma VL, Anand A. Role of early life exposure and environment on neurodegeneration: Implications on brain disorders. Transl Neurodegener. 2014;3:9.
-
(2014)
Transl Neurodegener.
, vol.3
, pp. 9
-
-
Modgil, S.1
Lahiri, D.K.2
Sharma, V.L.3
Anand, A.4
-
38
-
-
84879137604
-
Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease
-
Valor LM, Guiretti D, Lopez-Atalaya JP, Barco A. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. J Neurosci. 2013;33(25):10471-82.
-
(2013)
J Neurosci.
, vol.33
, Issue.25
, pp. 10471-10482
-
-
Valor, L.M.1
Guiretti, D.2
Lopez-Atalaya, J.P.3
Barco, A.4
-
39
-
-
34948867658
-
Extrapolating brain development from experimental species to humans
-
Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology. 2007;28(5):931-7.
-
(2007)
Neurotoxicology.
, vol.28
, Issue.5
, pp. 931-937
-
-
Clancy, B.1
Finlay, B.L.2
Darlington, R.B.3
Anand, K.J.4
-
41
-
-
40449086665
-
Dose translation from animal to human studies revisited
-
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-61.
-
(2008)
FASEB J.
, vol.22
, Issue.3
, pp. 659-661
-
-
Reagan-Shaw, S.1
Nihal, M.2
Ahmad, N.3
|